| Title | Date | File Size | Download |
|---|---|---|---|
| Striving to End Tuberculosis – A Strategy for Ireland 2024 - 2030 |
27 Mar, 2024 | 1,397.02 KB | Download |
| Evidence to decision: HIV PEP - Needlestick exposure from a discarded needle in the community and Shared injecting paraphernalia recommendations |
5 Mar, 2024 | 217.67 KB | Download |
| Evidence to decision: HIV PEP - Sexual exposure recommendations |
5 Mar, 2024 | 246.32 KB | Download |
| Evidence to decision: HIV PEP - Occupational exposure recommendations |
5 Mar, 2024 | 245.40 KB | Download |
| Evidence to decision: HIV PEP - Human bite exposure recommendations |
5 Mar, 2024 | 145.83 KB | Download |
| Summary of Recommendations: Guidelines for the Emergency Management of Injuries and Post-Exposure Prophylaxis (PEP) |
5 Mar, 2024 | 201.61 KB | Download |
| Table 4 - Hepatitis B post-exposure prophylaxis |
4 Mar, 2024 | 137.71 KB | Download |
| Table 11 - HIV PEP drugs, doses and side effects |
4 Mar, 2024 | 145.80 KB | Download |
| Table 10 - Suggested Paediatric PEP Regimens |
4 Mar, 2024 | 37.21 KB | Download |
| Table 9 - Estimated risk of HIV transmission by type of exposure where source HIV status is unknown |
4 Mar, 2024 | 123.04 KB | Download |
| Table 8 - Risk of HIV transmission per exposure where source is known to be living with HIV and not on ART |
4 Mar, 2024 | 68.26 KB | Download |
| Table 7 - Impact of suppressive antiretroviral therapy on risk of HIV acquisition |
4 Mar, 2024 | 92.17 KB | Download |
| Table 6 - HIV PEP recommendations by type of exposure and source status |
4 Mar, 2024 | 176.99 KB | Download |
| Table 5 - Baseline and follow up testing |
4 Mar, 2024 | 57.90 KB | Download |
| Table 3 - HIV Transmission risk by exposure type |
4 Mar, 2024 | 77.83 KB | Download |
| Table 2 - Hepatitis C transmission risk by exposure type |
4 Mar, 2024 | 118.71 KB | Download |
| Table 1 - Hepatitis B transmission risk by exposure type |
4 Mar, 2024 | 97.09 KB | Download |
| Management of Infection Risk from a Blood Borne Virus (BBV) following a needlestick or sharps injury in an Occupational or Community setting |
4 Mar, 2024 | 162.15 KB | Download |
| Management of Infection Risk following exposure of mucous membrane or non-intact skin to a Blood Borne Virus (BBV) in an occupational setting |
4 Mar, 2024 | 154.13 KB | Download |
| Management of Infection Risk from a Blood Borne Virus (BBV) following Sexual Exposure |
4 Mar, 2024 | 198.96 KB | Download |
| Management of Infection Risk from a Blood Borne Virus (BBV) following Human Bite breaching skin – or ‘fight bite’ |
4 Mar, 2024 | 160.29 KB | Download |
| Guidelines for the Emergency Management of Injuries (EMI) and Post-Exposure Prophylaxis (PEP) |
21 Feb, 2024 | 1,006.65 KB | Download |
| Summary of Recommendations: Guidelines for the Public Health Management of Contacts of Invasive Group A Streptococcus (iGAS) infection in Ireland. |
9 Feb, 2024 | 140.52 KB | Download |
| Template Letter to GP for close contacts of an iGAS case |
9 Feb, 2024 | 22.53 KB | Download |
| Template letter to GP for a case of iGAS |
9 Feb, 2024 | 20.13 KB | Download |
| Template letter for creche, school or other childcare setting |
9 Feb, 2024 | 19.60 KB | Download |
| Strep A (Group A streptococcus) factsheet |
9 Feb, 2024 | 177.18 KB | Download |
| Information leaflet for contacts of patients with Invasive Group A Streptococcal infection (iGAS) |
9 Feb, 2024 | 221.24 KB | Download |
| Template letter for GP – Close contact of iGAS case in an RCF setting |
9 Feb, 2024 | 708.22 KB | Download |
| Appendix 1: SIGN-GRADE |
8 Feb, 2024 | 107.52 KB | Download |
| Appendix 2: Glossary of acronyms and abbreviations |
8 Feb, 2024 | 100.17 KB | Download |
| Appendix 3: iGAS Guideline Development Group Membership |
8 Feb, 2024 | 155.87 KB | Download |
| Appendix 4: iGAS Factsheets |
8 Feb, 2024 | 83.53 KB | Download |
| Table 5: Infection, Prevention and Control measures for RCFs This document is Table 5 from the Guidelines for the Public Health Management of Contacts of Invasive Group A Streptococcus (iGAS) Infection in Ireland. |
8 Feb, 2024 | 150.07 KB | Download |
| Choice of agent for treatment of Group A Streptococcus (GAS) or chemoprophylaxis for a contact of invasive Group A Streptococcus (iGAS) This document is Table 4 from the Guidelines for the Public Health Management of Contacts of Invasive Group A Streptococcus (iGAS) Infection in Ireland. |
8 Feb, 2024 | 112.20 KB | Download |
| Algorithm 1: Management of contacts of a case of iGAS in a household setting |
8 Feb, 2024 | 99.32 KB | Download |
| Guidelines for the Public Health Management of Contacts of Invasive Group A Streptococcus (iGAS) infection in Ireland |
8 Feb, 2024 | 1,404.45 KB | Download |
| iGAS Guidelines References |
8 Feb, 2024 | 226.35 KB | Download |
| Chapter 6: Other congregate community settings |
8 Feb, 2024 | 200.17 KB | Download |
| Chapter 5: Residential care facility (RCF) settings |
8 Feb, 2024 | 631.91 KB | Download |
| Chapter 2: Single case of iGAS: risk assessment and identification of contacts |
8 Feb, 2024 | 297.02 KB | Download |
| Guidelines for the Public Health Management of Contacts of Invasive Group A Streptococcus (iGAS) Infection in Ireland - Chapter 4: Crèche, schools, and other childcare settings |
8 Feb, 2024 | 360.28 KB | Download |
| Chapter 3: Household settings |
8 Feb, 2024 | 224.53 KB | Download |
| Algorithm 2: Management of iGAS case linked to a creche, school or other childcare setting |
23 Jan, 2024 | 85.41 KB | Download |
| WGS Programme Sampling Framework Document Version 2.0 |
18 Jan, 2024 | 430.22 KB | Download |
| CPD titles 2024 |
1 Jan, 2024 | 121.42 KB | Download |
| Preventing Foodborne Disease: A Focus on the Infected Food Handler (2004) |
1 Jan, 2024 | 488.75 KB | Download |
| Interim Guidance Note on Managing Norovirus in Residential Care Settings This Guidance note provides a high-level overview of managing norovirus in residential care facilities, but its principles can be applied to any acute or community healthcare setting. |
7 Nov, 2023 | 300.00 KB | Download |
| Respiratory Virus Testing Capacity and Practices in Acute Hospital Settings in Ireland; Results from a National Laboratory Survey. |
6 Nov, 2023 | 722.49 KB | Download |
| Lyme disease and tick bites (poster) |
31 Oct, 2023 | 594.83 KB | Download |
Ireland’s specialist service for the surveillance of communicable diseases.